MicroPort Scientific Corporation (MSK.F)

0,8100 -0,0050 (-0,61%) Ab 08:12AM CEST. Markt geöffnet.

MicroPort Scientific Corporation

1601 Zhangdong Road
Zhangjiang Hi-Tech Park
Shanghai 201203
China
86 21 3895 4600
https://www.microport.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 8.230

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Zhaohua Chang Ph.D.	Founder, Chairman & CEO	185,43k	N/A	1963
Dr. Qiyi Luo Ph.D.	Non - Executive Director	236,42k	N/A	1962
Mr. Hongbin Sun	Chief Financial Officer	125,2k	N/A	1975
Dr. Jie Zhang	Chief Technology Officer	N/A	N/A	1980
Mr. Junder Chiang	Chief Human Resources Officer	N/A	N/A	1965
Mr. Jonathan H. Chen	Chief International Business Officer	N/A	N/A	1975
Ms. Wing Yan Yuen FCIS, FCS	Company Secretary	N/A	N/A	1970

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

MicroPort Scientific Corporation, an investment holding company, engages in the manufacture, marketing, and sale of medical devices in the People's Republic of China, North America, Europe, rest of Asia, South America, and internationally. The company's Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; and coronary stents, related delivery systems, balloon catheters, accessories, and active devices. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma products, and other professional implants and instruments. The company's Cardiac Rhythm Management Business segment offers defibrillators, cardiac resynchronization therapy devices, and pacemakers. Its Endovascular and Peripheral Vascular Devices segment provides disease solutions for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection aneurysms, and other arteriovenous related diseases. The company's Neurovascular Devices segment offers neurovascular therapeutic and access devices for cerebrovascular diseases. Its Heart Valve Business segment provides VitaFlow transcatheter aortic valve implantation and delivery system; VitaFlow Liberty transcatheter aortic valve implantation and retrievable delivery systems; Alwide Plus balloon catheter; AccuSniper double-layer balloon catheter; and various transcatheter aortic valve implantation, transcatheter mitral valve, transcatheter tricuspid valve, and procedural accessory products. The company's Surgical Robot Business segment offers surgical robots comprising robot ontology, control algorithm, electrical engineering, image-based navigation, and precision imaging. Its Surgical Devices segment provides surgical devices. It is also involved in the distribution of medical devices. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.

Corporate Governance

MicroPort Scientific Corporations ISS Governance QualityScore, Stand 1. Mai 2024, lautet 10. Die grundlegenden Scores sind Audit: 9, Vorstand: 10, Shareholderrechte: 7, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.